A 12-month course of combination therapy with interferon-? and ribavirin in chronic hepatitis due to coinfection with hepatitis B and C viruses

dc.contributor.authorYalcin, K
dc.contributor.authorDegertekin, H
dc.date.accessioned2024-04-24T17:18:31Z
dc.date.available2024-04-24T17:18:31Z
dc.date.issued2002
dc.departmentDicle Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.2165/00044011-200222110-00009
dc.identifier.endpage798en_US
dc.identifier.issn1173-2563
dc.identifier.issue11en_US
dc.identifier.scopus2-s2.0-0036441046
dc.identifier.scopusqualityQ2
dc.identifier.startpage797en_US
dc.identifier.urihttps://doi.org/10.2165/00044011-200222110-00009
dc.identifier.urihttps://hdl.handle.net/11468/18811
dc.identifier.volume22en_US
dc.identifier.wosWOS:000179422300009
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoenen_US
dc.publisherAdis International Ltden_US
dc.relation.ispartofClinical Drug Investigation
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleA 12-month course of combination therapy with interferon-? and ribavirin in chronic hepatitis due to coinfection with hepatitis B and C virusesen_US
dc.titleA 12-month course of combination therapy with interferon-? and ribavirin in chronic hepatitis due to coinfection with hepatitis B and C viruses
dc.typeLetteren_US

Dosyalar